Bellring Brands | BRBR | Long at $22.77Bellring Brands NYSE:BRBR , a consumer staples company focused on ready-to-drink protein shakes, powders, and bars. Its key brands are Premier Protein, Dymatize, and PowerBar.
Technical Analysis
Post-earnings, NYSE:BRBR fell through my "crash" simple moving average zone (green lines). This price area is often a location of algorithmic share accumulation. The final major stop is sometimes the my "major crash" zone (now between $15 and $20). However, the earnings results weren't terrible for $NYSE:BRBR. I think an overall market turn, recession announcement, or company debacle would be the only driving factors causing the price to hit near $15. Thus, in the near-term, there may be some temporary weakness, but the bounce today shows strength.
Growth
While slower than anticipated into 2026 (which many companies are reporting...), continued earnings and revenue growth into 2028 is anticipated: www.tradingview.com
Health
Cash king
No long-term debt
Very low bankruptcy risk (Altman's Z Score = 7+)
Trading at a good 15x P/E
Action
NYSE:BRBR is still a high-growth company. I think the price movement recently has simply been a reset due to previous overvaluation. While the economy shows signs of weakness, the niche this Bellring Brands operates in is growing and shows strength. However, caution if there is a market downturn or recession announcement - $15 or lower isn't out of the question. Outside of that, though, continued growth may prop this company further beyond late 2025 / early 2026. Thus, at $22.77, NYSE:BRBR is in a personal buy zone.
Targets into 2028
$30.00 (+31.8%)
$39.00 (+71.3%)
Protein
BRBR Power Bar and Protein Shakes Shakin' It UP!Fundamentals:
Meets my parameters for investing long-term.
Technicals:
Daily:
ExDiv1
Triples
161 extension, equal legs and weekly key fib meeting at the same spot (confluence)
New Crown high formed on the daily
Weekly:
uHd+hammerw/ d3 volume @ key fib pullback
morning star
Met monthly average range
Kijun signal
extreme indicator
Target 140 (tentatively), but will hold forever if I possible
Tentative rethinking point to buy more investment if it falls is about 48.
QSI Quantum-Si incorporated Potential ReentryIf you haven`t bought the Double Bottom on QSI:
Then it seems that there is a potential reversal from this level.
Earnings were a beat, but too small to justify the recent breakout.
The Elliot Waves chart pattern indicates a price target of $2.93.
Looking forward to read your opinion about it!
QSI Quantum-Si | Why is so Bullish? Price Target ! If you haven`t bought the Double Bottom here:
Then I'll try an explanation why QSI Quantum-Si incorporated is so Bullish right now!
QSI is a protein sequencing company, which could be revolutionary, similar to the gene sequencing stocks.
Quantum-Si Incorporated is dedicated to developing a protein detection platform that enables Next Generation Protein Sequencing (NGPS). This comprehensive platform consists of the Carbon automated sample preparation instrument, the Platinum single-molecule detection and NGPS instrument with Time-Domain Sequencing chip, the Quantum-Si Cloud data analysis software, and reagent kits designed for use with its instruments.
QSI's competitor, RXRX, experienced a significant boost in its stock price after announcing a $50 million investment from NVIDIA (NASDAQ: NVDA) on July 12. The investment was part of a private investment in public equity (PIPE) arrangement. With this deal, NVIDIA gains access to Recursion Pharmaceuticals' (NASDAQ: RXRX) extensive biochemical and genetic data. NVIDIA plans to utilize this data to train machine-learning models in support of its new BioNeMo service, an artificial intelligence (AI) tool for drug discovery. Simultaneously, NVIDIA will also collaborate with Recursion to enhance their own models for drug discovery.
Apart from Quantum-Si's Platinum product, which began selling this quarter, the company also offers cloud-based proteomics data analysis software, made possible by their single-molecule detection and NGPS instrument with Time-Domain Sequencing chip.
Considering this, I believe it's only a matter of time until a major chip developer, such as NVDA, or a cloud services company with interest in the field, makes an investment similar to NVDA's investment in RXRX.
This is my growth thesis, and regarding the Price Target, I find $10 to be reasonable for now, and there's also the possibility of a potential buyout.
Looking forward to read your opinion about it!



